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ABSTRACT Protein labeling with green ﬂuorescent protein derivatives has become an invaluable tool in cell biology. Protein
quantiﬁcation, however, is difﬁcult when cells express constructs with overlapping ﬂuorescent emissions. Under these con-
ditions, signal separation using emission ﬁlters is inherently inefﬁcient. Spectral imaging solves this problem by recording emission
spectra directly. Unfortunately, linear unmixing, the algorithm used for quantifying individual ﬂuorophores from emission spectra,
fails when resonance energy transfer (RET) is present. We therefore sought to develop an unmixing algorithm that incorporates
RET. An equation for spectral emission incorporating RET was derived and an assay based on this formalism, spectral RET
(sRET), was developed. Standards with deﬁned RET efﬁciencies and with known Cerulean/Venus ratios were constructed and
used to test sRET. We demonstrate that sRET analysis is a comprehensive, photon-efﬁcient method for imaging RET efﬁciencies
and accurately determines donor and acceptor concentrations in living cells.
INTRODUCTION
Imaging of proteins that have been genetically altered to
express spectrally distinct ﬂuorescent isoforms has revolu-
tionized cell biology. Experiments probing the interactions
of proteins, formerly limited to in vitro preparations and ﬁxed
specimens, can now be conducted inside living cells (1,2). In
vivo imaging of protein interaction falls into two general cate-
gories, colocalization and resonance energy transfer (RET).
Fluorescence imaging can be used to map intracellular dis-
tributions of putative interacting proteins labeled with speciﬁc
members of the green ﬂuorescent protein family (FPs) (3,4).
Spatial overlap between distributions can suggest intermolec-
ular relationships (5,6). The validity of colocalization analysis
is limited by the ability to obtain quantitative measurements of
the abundance of each ﬂuorescent species and by the resolution
of light microscopy.
RET imaging measures the nonradiative transfer of energy
from the excited state of a ﬂuorophore (called the donor) to
an adjacent acceptor molecule (7). Speciﬁcally, RET imag-
ing measures RET efﬁciency, the fraction of donor excitation
events that results in excitation of the acceptor. For RET to
occur, three requirements must be met. First, the emission
spectrum of the donor molecule must overlap with the ab-
sorbance spectrum of the acceptor. Second, the emission tran-
sition dipole of the donor must not be oriented perpendicular
to the absorbance transition dipole of the acceptor and, most
importantly, the donor and acceptor molecules must reside
within ;100 A˚ of each other. Because the RET efﬁciency
can be used to measure distances on the 10–100 A˚ scale, this
technique has been exploited to study protein-protein inter-
actions. The validity of RET-based distance measurements,
however, is limited by knowledge of the donor-acceptor
dipole orientation, by knowledge of the donor-acceptor
complex stoichiometry, and by the accuracy of the measured
RET efﬁciency. In turn, RET efﬁciencies are typically
estimated by measuring changes in the ﬂuorescence intensity
of the donor in the presence or absence of the acceptor.
Alternatively, RET efﬁciency can also be estimated by
measuring changes in the ﬂuorescence lifetime of a donor in
the presence or absence of an acceptor. To verify that energy
lost by the donor is indeed transferred to the acceptor,
a decrease in the ﬂuorescence intensity of a donor should be
matched by an increase in the ﬂuorescence intensity of the
acceptor. For ﬂuorescence lifetime decay curves, the lifetime
of the donor molecule should decrease with RET, and a new
kinetic component with a ‘‘negative lifetime’’ should appear
in the acceptor decay curve. Because of the difﬁculty in
isolating an acceptor’s ﬂuorescent signal from a donor’s
signal, ﬂuorescent lifetime analysis generally monitors the
donor lifetime only. Two technical difﬁculties often
encountered measuring RET efﬁciency are contamination
of the acceptor’s ﬂuorescent signal with the donor’s (bleed-
through) and the difﬁculty of exciting a donor without also
directly exciting the acceptor. Spectral imaging can poten-
tially overcome both of these problems (8,9).
Excitation and emission spectra of most FP members
overlap (10). Thus, they are excellent ﬂuorophores for RET
imaging studies. The overlap of emission spectra, however,
makes it both difﬁcult and inefﬁcient to use conventional
ﬁlter technology to acquire uncontaminated ﬂuorescent signals
of individual FPs in mixed populations. Spectral imaging, an
imaging modality that allows for the accurate measurement of
the abundance of ﬂuorophores with overlapping emission
spectra, can potentially overcome this limitation. In this study,
we demonstrate that by accounting for the effects of RET in the
complex ﬂuorescent emission spectra emanating from mixtures
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of potential donors and acceptors, spectral imaging can be used
to accurately measure donor and acceptor concentrations and
their RET efﬁciencies.
MATERIALS AND METHODS
Cloning and puriﬁcation of 6XHis-tagged proteins
Polymerase chain reaction (PCR) mutagenesis (11) was used to generate
6XHis-tagged Cerulean and Venus. PCR primers that hybridize to all FPs
(sense CTTCGAGCTGGACGGCGAC and antisense CTCCAGCAGGAC-
CATGTGATCG) were synthesized (Invitrogen, Carlsbad, CA) and used in
a ﬁrst PCR to generate 620 bp fragments from either Cerulean or Venus (gift
from Dr. H. Puhl and Dr. S. Ikeda, NIAAA, NIH). These fragments were
puriﬁed (PCR puriﬁcation kit from Qiagen, Valencia, CA) and used as the
primer in a second PCR where 6XHis-tagged enhanced cyan ﬂuorescent
protein (ECFP) or enhanced yellow ﬂuorescent protein (EYFP) (generous
gifts from Dr. G. Patterson (10)) were used as templates. The PCR products
were digested with Dpn I (New England Biolabs, Ipswich, MA) and used to
transform TOP 10 bacterial cells (Invitrogen). Cells were plated onto Lauria-
Bertani medium agar plates containing ampicillin (Fermentas, Hanover,
MD), and His-tagged Cerulean and Venus clones were picked and
sequenced.
For protein puriﬁcation, 6XHis-tagged Cerulean and Venus constructs
were transformed into BL21 Star (DE3) pLysS cells (Invitrogen) and grown
in 200 ml cultures for 4 h at 37C. Isopropyl thio galactoside (IPTG) (1 mM)
was then added, and cells were incubated at room temperature overnight.
Cells were spun down, resuspended in Lysis buffer (50 mM NaH2PO4, 300
mM NaCl, 10 mM imidazole; pH 8.0) and ﬂash frozen and thawed twice.
Insoluble debris from the cell lysate was removed by centrifugation, and the
supernatant was collected. Nickel nitroilotriacetic acid magnetic agarose
beads (50 ml, Qiagen) were added to each 0.5 ml aliquot of supernatant and
incubated at room temperature for 30 min. Magnetic beads were then
washed 13 in wash buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM
imidazole; pH 8.0). His-tagged proteins were eluted with 50ml of elution
buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM imidazole; pH 8.0). The
eluate was concentrated using Centricon ﬁlters (Amicon, Bedford, MA) and
resuspended in 10 mM Tris-HCl at pH 8.0. The concentrations of the
isolated FPs were determined using a spectrophotometer and Beers Law.
Absorption coefﬁcients and excitation wavelengths used were 43,000
M1cm1 at 433 nm for Cerulean (12) and 92,200 M1cm1 at 515 nm for
Venus (13).
Construction of expression vectors encoding
RET-stoichiometry standards
Cerulean-C1 and Venus-C1 expression vectors were generated by muta-
genesis of ECFP-C1 and EYFP-C1 (Clonetech, Mansﬁeld, UK) as described
above. These clones were sequenced and used as precursors for the con-
struction of all RET-stoichiometry standards. Standards composed of multiple
FPs required removal of internal start and stop codons. To generate con-
structs with two FPs, a sense primer containing a BglII site (GCAGATCT-
GTGAGCAAGGGCGAGGAGCTGTTCACC) and an antisense primer
containing EcoRI site (GCGAATTCCTTGTACAGCTCGTCCATGCC-
GAGAGTG) were used (high ﬁdelity Ultra-Pfu, Stratagene, La Jolla, CA).
The resultant Cerulean or Venus PCR products were puriﬁed and digested
using BglII (NEB) and EcoRI (NEB). Fragments were ligated into either
Venus C1 or Cerulean C1 to generate VC or CV. The two ﬂuorophores are
separated by a ﬁve amino acid linker in these constructs. Clones were se-
lected by size and conﬁrmed by restriction analysis. Furthermore, both blue
and yellow ﬂuorescent emission was detected from N1E cells transfected
with these constructs.
To generate constructs with three FP domains, we ampliﬁed full-length
Cerulean and Venus with SalI sense (GCGTCGACGGGTGAGCAAG-
GGCGAGGAGCTGTTCACCG) and BamHI antisense primers (GCGG-
ATCCCTTGTACAGCTCGTCCATGCCGAGAGTGATC). Puriﬁed Cerulean
PCR product was digested with SalI (Roche, Indianapolis, IN) and BamHI
(NEB) and ligated into the CV construct (described above) to generate CVC.
Likewise, puriﬁed Venus PCR product was digested with and ligated into the
VC construct to generate VCV. This resulted in proteins in which the second and
last FP domains were separated by a six amino acid linker. Clones were selected
by size and conﬁrmed by restriction analysis. Blue and yellow ﬂuorescent
emission was detected from cells transfected with these constructs.
A tumor necrosis factor receptor associated factor (TRAF) domain (229
amino acid) was PCR ampliﬁed from CFP-TRAF2TRAF-YFP (a gift from
Dr. L. He, NIAMS, NIH) primers ﬂanked by BspE1 (sense: AACTCCG-
GAGAGAGCCTGGAGAAGAAG, antisense: AACTCCGGAGAGCCC-
TGTCAGGTCCAC) sites (14).The puriﬁed PCR product was digested with
BspEI (NEB) and ligated into either Cerulean C1 or CV to generate the CT
and CTV constructs. Clones were selected by size and conﬁrmed by
restriction and sequence analysis.
Construction of g-Venus and b-Cerulean
ECFP-g- and EYFP-b-subunits of trimeric G-proteins (gifts from S. Ikeda
(15)) were used to construct N-terminally tagged g-Venus and b-Cerulean.
The g-Venus construct was generated by removing ECFP from ECFP-g and
replacing it with Venus. ECFP-g and Venus C1 were digested with Eco47III
(Roche) and BspEI (NEB). The Venus and g-vector products were gel
puriﬁed (QiaExII gel puriﬁcation kit, Qiagen), ligated (Rapid ligation kit,
Roche), and transformed into Top 10 bacteria. The cDNA coding for the
b-subunit was digested using EcoRI and ligated into Cerulean C1. Clones
expressing g-Venus and b-Cerulean were selected based on restriction
analysis. Sequencing conﬁrmed the presence of the respective G-protein
subunits, and the ﬂuorescent emission from transfected cells conﬁrmed the
presence of the appropriate FP.
Cell culture and transfection
N1E-155 mouse neuroblastoma cells were cultured in 89% Dulbecco’s
modiﬁed Eagle’s medium, 10% fetal bovine serum, and 1% penn/strep
(Invitrogen, Carlsbad, CA). Lipofectamine 2000 (Invitrogen) was used to
transfect all constructs using the protocol provided by the manufacturer, and
cells were imaged the following day.
Imaging
All imaging was performed using a Carl Zeiss (Jena, Germany) 510 META
nonlinear optics (NLO) scan head attached to an upright Zeiss Axioplan 2
microscope. A mode-locked Ti:sapphire laser (Coherent Chameleon,
Coherent, Santa Clara, CA), tunable from 710 to 950 nm was attached to
the NLO laser in-port of the scan head through an acoustic optic modulator.
Imaging of capillaries was performed using a 10 3 0.3 numerical aperture
(NA) air objective, and live-cell imaging was performed with a 203 NA 0.5
water objective. For two-photon spectral imaging, all 32 channels of the
internal META photomultiplier array were used, spanning an emission range
of 388–719 nm. A BG39 ﬁlter was placed in the detection light path to
prevent Ti:sapphire laser emissions from entering the detector assembly. For
linear unmixing, between four and eight spectral image scans were averaged
to reduce noise. Time-domain ﬂuorescence lifetime imaging (FLIM) and
spectroscopy were performed using the time-correlated single-photon
counting technique (TCSPC) (7,16). For donor lifetime analysis, Cerulean
was excited with a mode-locked laser tuned to 850 nm. Emitted photons
were ﬁltered through a BG39 ﬁlter, a polarizer set to 54.7, a 700 nm short-
pass ﬁlter (Chroma Optical (Rockingham, VT), e700sp-2p), and a 460–490
nm band-pass ﬁlter, and detected on a bialkali microchannel plate
photomultiplier (;10% quantum efﬁciency at 500 nm; Hamamatsu
(Hamamatsu City, Japan) R3809U-52) attached to a Zeiss 510 non-
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descanned detector port placed in the transmitted light pathway. For FLIM
analysis, photons were counted and correlated with excitation laser pulses
and XY scan head position using a Becker and Hickl (Berlin, Germany)
SPC830 module. The FLIM system was veriﬁed using calcium green
(Molecular Probes, Eugene, OR) in the presence and absence of calcium as
lifetime standards (17). For ﬂuorescence lifetime spectroscopy, the laser was
scanned over a region of interest, and detected photons were pooled,
counted, and correlated with excitation laser pulses to generate a single
ﬂuorescence lifetime decay curve.
Image processing and analysis
Image acquisition was controlled using Zeiss software release 3.2, and for
FLIM analysis, single photon counting module acquisition software from
Becker and Hickl was also used. Fluorescent lifetime decay curves for each
pixel were ﬁt to exponential decay models convolved with an estimate of our
system response function using single photon counting Image software from
Becker and Hickl. The average decay constant (tavg) for each pixel was
calculated and used to create pseudocolor mapped tavg images as well as
histograms of the distribution of average lifetimes in an image. Where
appropriate, RET efﬁciencies were calculated from decay constants or
average decay constants using Econstruct ¼ 1  tconstruct/tCerulean. Linear
unmixing of 32-channel spectral data sets was performed with custom
software written using Igor Pro (WaveMetrics, Lake Oswego, OR). This
software performed linear unmixing as described in Eq. 1 for three
channels—donor (Cerulean), acceptor (Venus), and background—
to create apparent donor and acceptor images with estimated standard devia-
tions calculated for each pixel. Reference spectra for unmixing were obtained
by imaging two square capillaries (100 mm 3 100 mm inner dimensions,
Vitrocom, Mt. Lakes, NJ) containing either pure donor or pure acceptor at
equal concentrations. Reference spectra were automatically baseline corrected
to remove dark counts. Similar results were obtained using linear unmixing
software from Zeiss, but reference baseline correction had to be performed
manually, and estimated deviations for each unmixing channel were not
calculated. Software for sRET analysis was also custom written using Igor
Pro. Paired spectral data sets were ﬁrst linearly unmixed as described above
to produce excitation wavelength-speciﬁc apparent donor and acceptor
images. Linear unmixing errors as estimated by the Levenberg-Marquardt
ﬁtting algorithm were propagated (assuming no correlated errors (18)), and
pixel values with errors.50% of their value were discarded. Equations 5, 6,
and 7 were applied to the apparent donor and acceptor images to generate
RET corrected donor images, acceptor images, and RET efﬁciency images.
RESULTS
Spectral imaging utilizes microscopes that collect ﬂuorescent
emission spectra for each pixel in an image. The complex
spectrum (Fcomplex) emitted by samples containing multiple
ﬂuorophores is assumed to be the linear sum of individual
component spectra (Fi, Fj, . . .) weighted by their abundance
(i, j, . . .) (19–21):
Fcomplex ¼ i3Fi1 j3Fj1 . . . (1)
Equation 1 is only valid in the absence of mechanisms
that selectively alter individual component spectra, such as
RET. Barring RET, and with knowledge of the types of ﬂuores-
cent species present as well as their individual unit emission
spectra, the abundance of each ﬂuorescent species in a sam-
ple can be mathematically extracted from a complex spectra.
(Unit emission spectra are deﬁned as the spectra emitted
from a ﬁxed amount of ﬂuorophore under deﬁned conditions
e.g., excitation wavelength, excitation power, the spectral
characteristics of detection pathway components). This pro-
cess, called linear unmixing, has been shown to qualitatively
separate the distribution of cyan ﬂuorescent protein (CFP)-,
green ﬂuorescent protein-, and yellow ﬂuorescent protein
(YFP)-labeled proteins in cells (22). Using unit reference
spectra for linear unmixing instead of the more commonly
used normalized emission spectra, obviates the need for factors
that take into account differences in absorption and quantum
yield of the molecules being quantiﬁed.
The RET problem
Because the emission and excitation spectra of most mem-
bers of the FP overlap, proteins labeled with these ﬂuoro-
phores can potentially transfer energy between each other
by nonradiative RET (23) if they reside within 100 A˚ of each
other (24). Under these circumstances, the observed emission
spectra (Fcomplex) from a mixture containing d molecules of
a donor ﬂuorophore with unit emission spectra Fd and amole-
cules of an acceptor ﬂuorophore with unit emission spectra Fa
will be
Fcomplex ¼ d3 ð1 EÞ3Fd1 a3Fa1 d3E3 ðFa=FdÞ
3 kðlÞ3Fa (2)
A detailed derivation of Eq. 2 is presented in the
Appendix. If Eq. 2 is valid and RET is not accounted for,
linear unmixing will underestimate the abundance of the
donor, d, by a factor of 1  E (where E is the RET efﬁ-
ciency), and the abundance of acceptor molecules, a, will be
overestimated by the product of d 3 E 3 (Fa /Fd) 3 k(l).
For mixed populations containing free donor, free acceptor,
as well as donor-acceptor complexes, the RET efﬁciency, E,
in Eq. 2 becomes the weighted average RET efﬁciency of
free donors (E ¼ 0) and donors transferring energy to ac-
ceptors (E . 0). By deﬁnition, a donor’s ﬂuorescence quan-
tum yield (Fd) is the number of photons emitted per photons
absorbed. For two-photon excitation, the quantum yield is
the number of photons emitted per twice the number of
photons absorbed. The energy absorbed by an acceptor, even
if acquired by RET, will be emitted by both the radiative and
nonradiative pathways of the acceptor. Thus, the ﬂuores-
cence emitted from an acceptor’s excited state is proportional
to its absorbed energy multiplied by its quantum yield (Fa ).
For energy transferred by RET, we must account for the
fraction of energy that normally would have been lost by
nonradiative pathways of the donor but were instead trans-
ferred to the acceptor and attenuated by its nonradiative
pathways. Therefore a correction factor of Fa/Fd is needed
to correct for the energy transferred in Eq. 2. This ratio is
a wavelength-independent constant speciﬁc for any partic-
ular pair of ﬂuorophores. The transfer factor k is an excitation
wavelength-dependent constant, speciﬁc for each donor-
acceptor pair and imaging system (k ¼ RFddl/RFadl).
Essentially, k is the ratio of a donor’s detected ﬂuorescence
2738 Thaler et al.
Biophysical Journal 89(4) 2736–2749
intensity (in the absence of an acceptor) divided by an
acceptor’s detected ﬂuorescence intensity (in the absence of
a donor) for equal concentrations of donor and acceptor.
RET efﬁciency typically is not affected by excitation wave-
length (excluding red-edge effects (25)).
The ratio of the number of photons transferred per photons
absorbed remains constant. In contrast, the probability for
exciting a ﬂuorophore does change with excitation wave-
length. In a population, more donor molecules will be excited
at the peak of their absorption spectrum than when excited at
less efﬁcient wavelengths. Thus, whereas RET efﬁciencies
do not change with excitation wavelength, the number of
donor molecules excited and consequently the net amount of
energy being transferred to the acceptor pool are a function
of excitation wavelength. The spectral manifestation of
energy transfer is a decrease in the magnitude of the donor
component of the complex emission spectrum, with a con-
comitant increase in the acceptor component. These changes
are observed as additions or subtractions from the spectral
emission of directly excited donors and acceptors. The
magnitudes of these directly excited spectral components are
also functions of the excitation wavelength. Equation 2 was
derived assuming conservation of photons. The k transfer
factor is used to incorporate photon conservation in Eq. 2.
To achieve this, the integral of the decrease in the donor
spectrum should equal the integral of the increase in the
acceptor spectrum (before adjusting for different quantum
yields). The k transfer factor adjusts for the fact that different
ﬂuorophores have different shaped emission spectra. If Eq. 2
is correct, linear unmixing using Eq. 1 will only produce
valid estimates of ﬂuorophore concentrations in the absence
of RET. Our goal was to use Eq. 2 to develop a method for
accurate quantitative linear unmixing despite the presence
of RET.
The development of RET standards of known
donor/acceptor stoichiometry
Controls with deﬁned RET efﬁciencies and stoichiometries
were needed to test the validity of Eq. 2, as well as to develop
and test a new comprehensive linear unmixing algorithm.
We genetically engineered a set of four DNA constructs en-
coding donor and acceptor FPs at speciﬁc ratios and different
RET efﬁciencies. To rigorously test unmixing algorithms
under a wide range of RET efﬁciencies and stoichiometries,
we wanted speciﬁcally 1), RET-positive and -negative con-
structs with the same acceptor/donor stoichiometry, 2), con-
structs with similar RET efﬁciencies but different acceptor/
donor ratios, and 3), a construct with a high RET efﬁciency
and excess acceptor. Cerulean, a blue FP derivative, was used
as a RET donor in these constructs because of its high
absorbance coefﬁcient 43,000 M1cm1, quantum yield
0.62, and because its ﬂuorescence decays with a single
exponential facilitating ﬂuorescence lifetime analysis (12).
Venus, a yellow FP derivative, was used as an acceptor in
these constructs because of its high absorbance coefﬁcient
92,200 M1cm1, quantum yield 0.57 (13), and because the
Cerulean to Venus Fo¨rster radius is 54 A˚ (D. Piston,
Vanderbilt University, personal communication, 2005). The
two-photon excitation-evoked emission spectra of Cerulean
and Venus are nearly identical to the emission spectra of CFP
and YFP. Changes in their intensity as a function of
excitation wavelength are shown (see Fig. 2). Two constructs
with a Venus/Cerulean stoichiometry of 1:1 were generated,
termed ‘‘CTV’’ and ‘‘CV’’ (Fig. 1 a). In the CTV construct
the Cerulean domain is separated from the Venus domain
using a 229 amino acid linker encoding the TRAF domain of
human TRAF2 (26). The crystal structure of a TRAF domain
has been solved and predicts at least an 80 A˚ distance
between Cerulean and Venus in the CTV construct (26).
A construct similar to CTV but using CFP and YFP as
donor and acceptor has been generated and expressed little if
any RET (14). The RET efﬁciency of the CTV construct was
measured using ﬂuorescence lifetime spectroscopy. N1E
cells were transfected with DNA encoding either CTV,
Cerulean alone (Fig. 1 a, ‘‘C’’), or Cerulean ligated to the
TRAF2 domain, ‘‘CT’’ (but without Venus). Fluorescence
lifetime spectroscopy was used to measure decay times of the
Cerulean ﬂuorescence using these constructs. The ﬂuores-
cent decays observed were all well ﬁt by a single exponential
decay model. The decay curves for C and CT were identical,
whereas that of CTV was slightly faster (Fig. 1 b), suggesting
that a small amount of RET was occurring in the CTV con-
struct. The ﬂuorescent decay constants (t) of CTV and CT
constructs were used to calculate a RET efﬁciency for the
CTV construct: 6.3% 6 2.6% (mean 6 SD, n ¼ 30). RET
efﬁciency is expressed as the percentage of energy trans-
ferred from donor to acceptor (E3 100). In contrast, the CV
construct was generated by ligating Cerulean to Venus using
a ﬁve amino acid linker. The ﬂuorescence lifetime decay of
Cerulean ﬂuorescence emanating from cells transfected with
the CV construct was faster than the ﬂuorescent decay of
Cerulean alone (Fig. 1 b), indicating that the CV construct is
undergoing RET. Its decay was poorly ﬁt by a single
exponential model, suggesting that a distribution of sep-
aration distances exists between Cerulean and Venus in this
construct (7). Nonetheless, an estimate of the CV average
RET efﬁciency can be calculated by measuring its average
decay time (7). Its decay was well ﬁt by a double exponential
and yielded an average RET efﬁciency of 43.1% 6 6.1%
(n¼ 20) when compared to the decay time of Cerulean alone.
To generate a construct with the same RET efﬁciency as the
CV construct, but with a different Venus/Cerulean stoichi-
ometry, CVC was constructed by ligating Cerulean cDNA
to the N- and C-terminus of Venus (Fig. 1 a). The Venus/
Cerulean stoichiometry of this construct is 1:2. For quan-
titative ﬂuorescence microscopy to be accurate, it is essential
that only small fractions of ﬂuorescent molecules be excited
at any instant. Cerulean emission count rates, measured
through a 475 6 15 nm ﬁlter, were always below 20,000
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photons/s (the recommended limit of the Hamamatsu
R3809U-52 detector).
The excitation frequencies in our experiments were set by
the laser pulse rate (90 MHz). Essentially, ,1 out of every
4500 laser excitation pulses resulted in a detected emission.
We reasoned that under these imaging conditions, it is
unlikely that more than a single ﬂuorescent protein domain
of any individual CVC molecule will be excited in response
to a single laser pulse. A low probability for ﬂuorescence
excitation was conﬁrmed by the invariance of the ﬂuores-
cence lifetime of Cerulean in the CVC construct when
excited at different laser powers (1.5–7.2 mW at 850 nm
measured through a 20 3 0.5 NA objective at the sample; see
Supplemental Fig. 1). Accordingly, the infrared excitation
power typically used in all live-cell lifetime experiments was
kept below 5 mW. Because the distance from each Cerulean
domain to the central Venus domain is comparable and likely
composed of a distribution of separation distances (and
almost certainly a distribution of transition dipole angles),
the CVC RET efﬁciency should be comparable to that of CV.
As expected, the CVC ﬂuorescent decay curve was virtually
identical to the decay curve of the CV construct (Fig. 1 b)
and yielded an average RET efﬁciency of 41.4% 6 3.2%
(n¼ 20). Finally, we assembled VCV (Fig. 1 a), with a Venus/
Cerulean stoichiometry of 2:1. We reasoned that a Cerulean
domain ﬂanked on both sides with Venus domains should
FIGURE 1 Characterization of RET efﬁciency standards with known donor/acceptor stoichiometries. (a) Construct maps of ﬂuorescence lifetime controls
(C and CT) as well as constructs with 1:1 Venus/Cerulean stoichiometry (CTV and CV), 1:2 stoichiometry (CVC), and 2:1 stoichiometry (VCV). (b) Cerulean
ﬂuorescence lifetime decay curves using a 475 6 15 nm emission ﬁlter obtained from cells expressing the six constructs. Dark count values were subtracted
from each curve. (c) Two-photon laser scanning spectral images acquired at 870 nm (CTV and CV) or 890 nm (CVC and VCV) excitation. Size bars are 10 mm.
(d) Cells expressing the RET-positive CV construct (circles) or the RET-negative CTV constructs (squares) were spectrally imaged. These images were
processed by linear unmixing as described by Eq. 1 to generate apparent concentrations for Cerulean (blue symbols) and Venus (yellow symbols) from each
construct. Each point is mean 6 SD, n ¼ 3 cells.
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have a higher RET efﬁciency than CVC because in its
excited state, Cerulean would have two RET de-excitation
pathways instead of just one. As expected, the VCV ﬂuo-
rescence decayed faster than ﬂuorescence emanating from all
of the other constructs (Fig. 1 b). The VCV ﬂuorescent decay
was poorly ﬁt by a single exponential but was well ﬁt by
a double exponential. Its average RET efﬁciency was found
to be 64.5% 6 3.2% (n ¼ 20). N1E cells transfected with
these four constructs and imaged by two-photon excitation
showed even ﬂuorescence throughout the cytoplasm (Fig.
1 c). Unlike the other three constructs, CTV appeared to be
occluded from the nucleus. This suggests that the central
TRAF2 domain of CTV facilitates the formation of large
rigid trimeric structures consistent with the literature that
effectively separate Cerulean from Venus in this construct.
Linear unmixing produces erroneous result in
the presence of RET
Having measured RET efﬁciencies in our constructs through
lifetime analysis, we next wanted to test the validity of Eq. 2
using our RET- negative and positive standards. Linear un-
mixing of a spectral data set yields an apparent donor con-
centration (dapparent) and an apparent acceptor concentration
(aapparent). If Eq. 2 is valid, the apparent donor concentration,
measured by linear unmixing, will remain constant at all
excitation wavelengths:
dapparent ¼ d3 ð1 EÞ (3)
In contrast, the apparent acceptor concentration will vary
with excitation wavelength if RET is occurring:
aapparentðlÞ ¼ a1 ðd3E3 ðFa=FdÞ3 kðlÞÞ (4)
To test these predictions, we transfected cells with DNA
encoding either CTV or CV. Both constructs have a Venus/
Cerulean stoichiometry of 1:1, but CTV was virtually RET
negative whereas CV is RET positive. Transfected cells were
excited by two-photon absorption at 850, 880, 920, and 940
nm and emission spectra collected for linear unmixing
analysis. As predicted, the apparent Cerulean concentration
from the CTV and CV constructs did not change with ex-
citation wavelength (Fig. 1 d). Similarly, the apparent Venus
concentration of CTV, the low RET construct, did not
FIGURE 2 (a) Excitation wavelength-dependent
changes in the two-photon emission spectra of Cerulean
(15 mM) and Venus (15 mM). Puriﬁed FPs were placed in
square microcapillaries and were excited with a mode-
locked Ti:sapphire laser tuned to emit at 850, 870, 890,
920, and 940 nm. At all wavelengths the laser power
exiting the objective was adjusted to 37 mW. Individual
spectra are the average of 49 individual pixels, and each
pixel’s spectrum was the average of 16 scans. Standard
Zeiss calibration of the META photomultiplier array
compensated for nonuniform detection efﬁciencies at
different wavelengths, and a dark noise adjustment was
made by subtracting values in the lowest emission channel
(385 nm) from all other channels. Potential changes in laser
pulse width and in the two-photon excitation volume (36)
as a function of laser wavelength were not accounted for in
this ﬁgure. Although these factors can signiﬁcantly alter
the shape of the emission spectra as reported here, they
were not a factor in our linear unmixing analysis because
Cerulean and Venus reference standards were measured
always at laser settings identical to when cells were
spectrally imaged. (b) The integral of Cerulean (blue
circles) and Venus (yellow diamonds) emission spectra, as
well as k (red squares), the ratio of these integrals, are
plotted as a function of a two-photon excitation wave-
length.
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change with excitation wavelength. In contrast, the apparent
Venus concentration of CV, the RET-positive construct, did
change with excitation wavelength (Fig. 1 d). The apparent
Venus and Cerulean concentrations of the CTV construct
were identical as expected for a 1:1 stoichiometry, support-
ing the conclusion that in the absence of RET, apparent
concentrations generated by linear unmixing are accurate
estimates of the true concentrations. In stark contrast, stoi-
chiometries calculated using the apparent Venus and Ceru-
lean concentrations of the RET-positive CV construct were
different at each excitation wavelength tested and ranged
from 4:1 (940 nm excitation) to 20:1 (850 nm excitation).
Because the predictions of Eq. 2 were observed, we conclude
that it is a valid model which describes the complex emission
spectra generated by a mixture of a RET donor and acceptor.
Furthermore, we conclude that linear unmixing with Eq. 1
will produce erroneous values if RET is occurring.
Spectral RET analysis
Having demonstrated the failure of linear unmixing in the
presence of RET, we then focused on developing a method
based on Eq. 2 to accurately measure the concentration of
spectrally overlapping FPs even if they are close enough to
transfer energy by RET. Equation 2 has three unknowns, d,
the donor concentration, a, the acceptor concentration, and
E, the RET efﬁciency. Linear unmixing at any excitation
wavelength yields two observables, dapparent and aapparent.
The apparent donor concentration is a function of d and E,
whereas aapparent is a function of a, d, E, and of the excita-
tion wavelength through the k constant. Thus, it is clear that
the information embedded in a single spectral data set is
insufﬁcient to solve for all three unknowns. In contrast, two
spectral data sets acquired at two different excitation
wavelengths with different k values should have sufﬁcient
information to solve for all three unknowns. Emission
spectra and excitation wavelength-dependent k values for
two-photon excitation of Cerulean and Venus are shown in
Fig. 2. The normalized emission spectra of the individual
FPs, acquired at different excitation wavelengths, were indis-
tinguishable (data not shown).
We derived solutions for d, a, and E by solving the sim-
ultaneous equations that describe the values of dapparent and
aapparent when acquired at excitation wavelengths A and B:
dapparent ¼ d3 ð1 EÞ
aapparentðlAÞ ¼ a1 ðd3E3 ðFa=FdÞ3 kðlAÞÞ
aapparentðlBÞ ¼ a1 ðd3E3 ðFa=FdÞ3 kðlBÞÞ
Simpliﬁed by substitutions,
Da ¼ aapparentðlBÞ  aapparentðlAÞ
Dk ¼ kðlBÞ  kðlAÞ
QD ¼ dapparent3 ðFa=FdÞ
we solved for d, a, and E:
d ¼ ðDa1QD3DkÞ=½ðFa=FdÞ3Dk (5)
a ¼ ½kðlBÞ3aapparentðlAÞ  kðlAÞ3 aapparentðlBÞ=Dk (6)
E ¼ Da=½Da1QD3Dk (7)
A computer algorithm that combines linear unmixing of
two spectral data sets with these three equations was de-
veloped to generate images of the RET-corrected donor
distribution, the RET-corrected acceptor distribution, and
the RET efﬁciency. We call this new algorithm spectral RET
or sRET. Furthermore, the RET-corrected acceptor image can
be divided by the RET-corrected donor image to generate
a pixel stoichiometry image. Accurate sRET analysis is de-
pendent on the precision of the unit emission spectra used
for linear unmixing at any speciﬁc combination of excitation
wavelength and laser power. It also requires an accurate
measurement of ﬂuorophore concentration when these ex-
perimental parameters are determined. Theoretically, unit emis-
sion spectra and the k-factors derived from them are constants
that can be measured once for any given microscope setup and
imaging condition. In practice, however, variance in emission
power, wavelength, bandwidth, or pulse width of a Ti:sapphire
laser, particularly upon wavelength tuning, precludes the use of
predetermined unit emission spectra. To circumvent this instru-
mental limitation, unit emission spectra are measured immedi-
ately before and after an sRET determination. A typical sRET
measurement involves tuning the excitation laser to the ﬁrst of
the two wavelengths used and adjusting the excitation power. A
slide containing two capillaries with either 7.8 mMCerulean or
7.8 mM Venus is spectrally imaged to obtain unit reference
spectra for both ﬂuorophores. This slide is removed and re-
placed with a dish containing transfected cells. These are spec-
trally imaged under the identical conditions. Next, the laser is
tuned to the second wavelength and the power is adjusted. The
cells are again spectrally imaged at this second wavelength.
Finally, the dish with the transfected cells is removed and
replaced with the same capillary slide previously used. This
slide is spectrally imaged at the second wavelength. Capillary
slide spectral images, obtained at the two wavelengths, are used
to generate unit reference spectra at each wavelength for both
Cerulean and Venus, as well as to generate k-factors for each
excitation wavelength. The unit spectra obtained at the two
excitation wavelengths are used to linearly unmix the corres-
ponding spectral images of the cells. The k-factors measured at
each wavelength are used in Eqs. 5, 6, and 7 to calculate donor
concentration, acceptor concentration, and RET efﬁciency. An
overview of the major data processing steps involved in sRET
analysis is shown in Fig. 3.
Evaluation of sRET analysis
To test the validity of sRET analysis, we transfected cells
with DNA encoding the CTV, CV, CVC, and VCV
constructs. Spectral data sets were acquired at 890 and 940
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nm excitation for the CTV and CV data sets and at 870 and
920 nm excitation for the CVC and VCV data sets. Although
theoretically any two wavelengths with different k values
should yield similar results from linear unmixing (see Fig. 2),
selection of excitation wavelengths that excites one ﬂuorophore
much better than the other will impair the precision of these
measurements. The VCV sample when excited at 940 nm
displayed a very high yellow signal resulting from its
high RET efﬁciency and from its stoichiometry. The large
yellow component of its complex spectrum dictated the
dynamic range of our acquisition, and thus limited the ac-
curacy of measuring the relatively weak blue signal of VCV.
By shifting excitation wavelengths down by 20 nm, we could
boost the VCV blue signal relative to its yellow signal and
thus acquire more precise measurements of dapparent. Spectral
data sets were linearly unmixed to generate Ceruleanapparent
and Venusapparent images. The Venusapparent images acquired
at 870 or 890 nm were used as aapparent(lA) in Eqs. 5, 6, and
7, whereas the Venusapparent images acquired at 920 or 940
nm were used as aapparent(lB).? The Ceruleanapparent images
acquired at each excitation wavelength were similar (data not
shown, but see Fig. 1 d), and an average of both apparent
Cerulean images were used as dapparent. Application of Eqs.
5, 6, and 7 using the apparent Venus and Cerulean images
produced donor images (Fig. 4 a, top row; Cerulean),
acceptor images (second row; Venus), and RET efﬁciency
images (bottom row) for each construct. Dividing the Venus
image by the Cerulean image produced a V/C ratio image
(third row). Because Cerulean and Venus are linked at set
stoichiometries in all four constructs, the images mapping
the distribution of Cerulean and Venus for each construct
were similar. The ratio image of Venus divided by Cerulean
(Fig. 4 a, third row) reveals each constructs’ stoichiometry.
The yellow images of CTV and CV indicated a 1:1 Venus/
Cerulean (V/C) stoichiometry. The CVC image was orange,
whereas the VCV image was green. These colors indicate
that CVC has a 1:2 Venus/Cerulean stoichiometry and VCV
has a 2:1 stoichiometry. Histograms of the V/C pixel values
(acceptor/donor) of these images are shown in Fig. 4 b. The
V/C stoichiometries of the constructs are revealed by the
position of the peaks in these histograms. The average peak
ratio of cells transfected with CTV had a Venus/Cerulean
ratio of 0.89 6 0.40 (mean 6 SD, n ¼ 12 experiments); this
was indistinguishable from a ratio of 1 as determined by
a one-sample t-test. Likewise, cells transfected with CV had
a V/C ratio of 1.01 6 0.29 (mean 6 SD, n ¼ 12). Cells
transfected with CVC or VCV had V/C ratios of 0.496 0.26
(mean6 SD, n¼ 6) and 2.096 0.96 (n¼ 6), respectively, in
good agreement with the theoretical values for these con-
structs of 0.5 and 2. ANOVA analysis indicated that CTV
and CV had the same V/C ratio but differed from the V/C
ratios of CVC and VCV.
RET efﬁciency images generated by sRET analysis were
mapped to a red-white-blue color map with red indicating
positive RET efﬁciencies, white indicating no RET, and
blue indicating negative RET values. Cells expressing CTV
mapped white, CV and CVC expressing cells mapped pink,
and VCV expressing cells mapped red (Fig. 4, a bottom row).
Histograms of these RET efﬁciency images reveal that CTV
had a RET efﬁciency of 0%, CV and CVC had RET
efﬁciencies of ;40%, and VCV had a RET efﬁciency of
almost 70% (Fig. 4 c). On average, cells transfected with CTV
had RET efﬁciencies of 1.7% 6 7.0% (mean 6 SD, n ¼ 12),
in agreement with the value of 6.3% 6 2.6% obtained from
lifetime analysis. Cells transfected with CV and CVC had
RET efﬁciencies of 45.3% 6 5.4% (n ¼ 12) and 41.2% 6
4.5% (n ¼ 6), respectively. These values were indistinguish-
able from each other and from the RET efﬁciencies measured
for these constructs by lifetime spectroscopy (as determined by
ANOVA). The VCV RET efﬁciency measured by sRET
analysis was 69.7% 6 5.7% (n ¼ 6) and compared well with
the efﬁciency measured by ﬂuorescence lifetime spectroscopy
FIGURE 3 sRET image processing (from left to
right). Two spectral image stacks are acquired at two
different excitation wavelengths, along with unit
reference spectra of isolated Cerulean and Venus in
capillaries (not shown in diagram). Excitation wave-
lengths are selected to maximize different k(l) values
at each wavelength while maintaining strong donor
and acceptor signals relative to the noise level. Linear
unmixing produces an apparent donor and acceptor
image from each image stack. The apparent donor im-
ages for both excitation wavelengths should be identi-
cal and are averaged to produce the donor apparent
image (not shown). Equations 5, 6, and 7 are used
to process the apparent donor and acceptor images
and yield a donor, acceptor, and RET efﬁciency
image. Finally, the acceptor image is divided by the
donor image to produce a stoichiometry image (a/d).
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(64.5% 6 3.2%). Because sRET analysis predicted the correct
V/C ratio and RET efﬁciency (as determined by ﬂuorescence
lifetime spectroscopy) of all four constructs, we conclude that
sRET is a valid algorithm for measuring the abundance of
donor and acceptor molecules in the presence and absence of
RET.
RET analysis with variable
donor/acceptor stoichiometries
We next wanted to demonstrate the utility of sRET in con-
ditions where the acceptor and donor molecules were not co-
valently linked. For this purpose, we used b- and g-subunits
of trimeric G-proteins since crystal structures reveal that they
FIGURE 4 Validation of sRET analysis. (a) After spectral imaging and linear unmixing, paired apparent donor and acceptor images were used to generate
RET-corrected Cerulean images (top row), Venus images (second row), and RET efﬁciency images (bottom row) for each of the four RET and stoichiometry
standards characterized in Fig. 2. A V/C ratio image was also generated by dividing the Venus images by the Cerulean images (third row). Pixel values were
mapped to the color look-up tables presented to the right of each row. (b) A histogram of acceptor to donor pixel values for each of the four constructs generated
from the V/C images shown above. (c) A histogram of RET efﬁciency pixel values for each of the four constructs generated from the RET efﬁciency images
shown above. Dashed black line indicates 0 RET.
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form dimers (27). Further, both b- and g-subunits are
biologically active when FPs are attached to their N-termini
(15). Transfection of b-Cerulean and g-Venus into N1E cells
showed that RET does indeed occur between these two
constructs; FLIM similarly conﬁrms the presence of RET
(Fig. 5). Similarities between RET efﬁciency as determined
through sRET or FLIM are remarkable considering that
two entirely different approaches to measuring RET efﬁ-
ciency were applied (Fig. 5, b and c). Nevertheless, it is
important to point out that sRET, unlike FLIM, was not
limited to measuring RET efﬁciencies; concentrations of
Cerulean and Venus are also revealed using sRET analysis
(Fig. 5 a).
The interpretation of RET imaging in general is severely
limited when proteins of interest or their binding partners are
endogenously expressed. Under these conditions, individual
cells will contain an unknown number of unlabeled binding
partners for labeled donors, resulting in underestimates of the
true RET efﬁciency of any given molecular complex. The
cell imaged in Fig. 5 a is an example of this circumstance
because in this cell the donor concentration was greater than
the acceptor concentration. Nevertheless, knowledge of donor
and acceptor concentrations as provided by sRET analysis
adds considerably to the ability to interpret RET efﬁciencies
in terms of protein-protein interactions.
DISCUSSION
We have shown that linear unmixing produced erroneous
results in samples that transferred energy by RET (Fig. 1 d).
To overcome this limitation, we developed and tested a new
algorithm for the analysis of spectral data that accounts for
RET activity. Using standards with known donor/acceptor
stoichiometries and with RET efﬁciencies measured by ﬂuo-
rescent lifetime analysis, sRET analysis accurately measured
donor and acceptor stoichiometries in the presence of 0%,
40%, and 70% RET (Fig. 4). Thus, spectral imaging with
FIGURE 5 sRET analysis accurately detects RET in
samples with low RET efﬁciencies and independent donors
and acceptors. Cells were transfected with the b-Cerulean,
g-Venus, and unlabeled a-subunits of trimeric G-proteins.
(a) sRET donor and acceptor images showing different
intracellular distributions of b-Cerulean and g-Venus. (b)
RET efﬁciency images generated by sRET analysis (left)
and FLIM-RET analysis (right). Note the absence of signal
over the nucleus and near the cell surface in the FLIM-RET
image. (c) A histogram of RET efﬁciency pixel values
generated by sRET analysis (red) and FLIM-RET analysis
(blue). Dashed black line indicates 0 RET.
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sRET analysis is an ideal method for measuring the abun-
dance of two ﬂuorophores with overlapping excitation and
emission spectra when the possibility of RET cannot be
eliminated.
Although sRET analysis was primarily developed as
a method for quantifying overlapping FP signals in living
cells, it is also a straightforward method for measuring RET
activity. RET efﬁciency values for our constructs, as
determined by sRET analysis, was virtually identical to the
values generated by ﬂuorescence lifetime decay analysis
(for example, compare Figs. 1 b and 4 c). In some previous
studies, RET efﬁciency, as well as the abundance of donors
and acceptors, have been measured from data sets acquired
using conventional ﬁlter-based data acquisition systems
(28–30). Analyses of these data sets utilize complex correc-
tion factors to compensate for spectral bleed-through, and
the direct excitation of an acceptor at the donor’s excitation
wavelength. In contrast, sRET analysis is based on a linear-
unmixing algorithm using spectral data sets. Linear unmixing
inherently corrects for bleed-through artifacts, which plague
ﬁlter-based RET measurements. Furthermore, rather than
being hindered by simultaneous direct excitation of both
donor and acceptor, sRET analysis exploits this phenomenon.
Equation 2, the basis for sRET analysis, models the complex
spectra emitted from a population containing a mixture of two
ﬂuorophores.
The equation has three terms that are added to deﬁne the
complex emission spectrum. The ﬁrst term accounts for the
emission from the donor population. The second term
accounts for acceptor emission stimulated by direct excita-
tion. The third term accounts for acceptor emissions stim-
ulated by RET. Because the direct excitation of both donors
and acceptors are accounted for in Eq. 2, theoretically RET
should be measurable under conditions that excite both do-
nors and acceptors, even when the majority of the donor
emission is stimulated by direct excitation. Practically, how-
ever, sRET analysis is limited by the signal/noise ratio of the
measured experimental spectra and by the dynamic range
and resolution of the data acquisition hardware. When either
the donor’s or the acceptor’s emission component is sig-
niﬁcantly brighter than the other’s, its ﬂuorescent signal will
determine the dynamic range for data acquisition. As the
magnitude of the weaker signal approaches the data acqui-
sition digitization resolution, the accuracy of that compo-
nent’s signal will be compromised. In the imaging system
used in this study, data were acquired at 12 bit resolution.
Thus, with a reasonable signal/noise ratio, it should be pos-
sible to accurately measure the emission from both donors
and acceptors, even when one is 10 times as bright as the
other. Judicious selection of excitation wavelengths for a
particular sample can alter the intensities of the emissions
from the two ﬂuorophores. An evaluation of the signal pro-
cessing statistics for sRET analysis is warranted to identify
the dominant sources of noise in the system, to optimize the
procedure, and to better deﬁne its operation limits. Finally,
because spectral imaging utilizes photons spanning the
complete emission spectrum of a sample, sRET analysis is
intrinsically more efﬁcient than ﬁlter-based methods that use
only a fraction of the emission spectrum.
Several methods have been developed for RET imaging in
living cells (29,31–34). Of these, FLIM-RET is one of the
most widely accepted. In our study we show how spectral
imaging can be used to measure RET efﬁciencies. FLIM-
RET analysis was used as a control to validate our spectral
method, and for the same samples both sRET and FLIM-
RET yielded similar RET efﬁciencies. At this point, it is
unclear if a general evaluation of the relative merits of
spectral imaging and FLIM for RET analysis can be reached.
Different laboratories and manufacturers are actively working
to optimize the efﬁciency of these techniques, but few mi-
croscopes exist that incorporate the latest optimizations for
both technologies. For our study FLIMwas incorporated into
a commercial multiphoton spectral imaging system (Zeiss
META/NLO) using off the shelf time-domain FLIM com-
ponents (Becker and Hickl and Hamamatsu). No modiﬁca-
tions were made to optimize photon efﬁciency in the spectral
detector light path. Similarly, the FLIM detector light path
was implemented per the manufacturers design. Time-domain
FLIM using streak cameras and frequency-domain FLIM
were not evaluated to optimize FLIM efﬁciencies. Direct
comparison of the photon efﬁciency of FLIM and sRET is
complicated by the fact that different excitation wavelengths
are used for these analyses. To maximize Cerulean and min-
imize Venus ﬂuorescence (see Fig. 2 b), 850-nm excitation
was used for FLIM analysis. Accurate FLIM measurements
require the isolation of the donor signal from the acceptor
signal, particularly in samples containing either high con-
centration of acceptor or high RET efﬁciencies. Signal
isolation is achieved by thoughtful selection of excitation
wavelength, as well as by the use of band-pass ﬁlters. These,
however, decrease the photon efﬁciency of the process by
limiting FLIM data acquisition to a fraction of the donor’s
emission spectrum. In contrast, sRET analysis utilized ex-
citation wavelengths between 870 and 940 nm to maximize
excitation of both Cerulean and Venus, and the full emission
spectrum of both the donors and the acceptors were collected.
Furthermore, the average laser power in FLIM measurements
was typically limited to ,7 mW because of the maximum
allowable photon count rate of the FLIM detector (Hamamatsu
R3809U-52; 20,000 cps), as well as by pile-up errors caused by
detector dead-time counting statistics at high count rates.
Because the spectral detector used in the ZeissMETA system is
not operated in a photon-counting mode, these limitations do
not directly apply for sRET analysis. For live-cell spectral
imaging, excitation power was limited to ,10 mW, primarily
to prevent ﬂuorophore bleaching and to avoid photodamage.
Despite the differences in excitation wavelength and
power used in FLIM and sRET experiments, our study
places us in a unique situation to compare the practical merits
of these two methods for live-cell RET imaging. Obviously,
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any comparison is limited to our speciﬁc implementation of
these two methods. In our experiments, the times required for
sRET imaging and FLIM imaging were signiﬁcantly dif-
ferent. The spectral data sets used to produce sRET images
(as in Fig. 5) consisted of two sets of 32 ; 10 nm wide
wavelength channels spanning emissions from 388 to 719
nm. Each 32-channel spectral data set was acquired in 25 s,
thus 50 s were required, not including time for tuning the
laser between data sets (typically 7.5 6 1.4 s, n ¼ 6) or the
time to image reference capillaries containing donor or
acceptor (;50 s at each wavelength for both wavelengths).
Potentially, this time can be signiﬁcantly shortened. Linear
unmixing does not signiﬁcantly suffer from a reduction in
the number of spectral channels used (35). On our imaging
system, a reduction from 32 spectral channels to 8 would
reduce the acquisition time from 50 to 12.5 s. Furthermore,
a system with two Ti:sapphire lasers pretuned to the required
excitation wavelengths would eliminate the time required for
laser tuning and also allow premeasurement of reference
spectra for each ﬁxed excitation wavelength, albeit at great
expense. In contrast, the FLIM data set used to generate the
image in Fig. 5 b was acquired in 300 s. Additionally,
binning of pixels (3 3 3) was required to produce decay
curves with sufﬁcient photon counts for curve ﬁtting to
a single-exponential lifetime model. A data set with enough
photon counts for ﬁtting a multiexponential lifetime model
would require signiﬁcantly longer acquisition times. The
effects of binning, a form of spatial averaging that sacriﬁces
resolution to increase signal strength, can be seen in the
FLIM-RET image in Fig. 5 b. The sRET image, with its
higher spatial resolution, appears speckled. In contrast, the
spatially averaged FLIM image appears as a uniform, solid
color. Furthermore, even with binning, there were insuf-
ﬁcient numbers of photons detected over the nucleus and cell
periphery to measure ﬂuorescent lifetimes (compare sRET
and FLIM-RET in Fig. 5 b). The acquisition time for FLIM
imaging could potentially be reduced by using a gallium-
arsenide-phosphide photomultiplier tube (40% quantum
efﬁciency at 550 nm), though temporal resolution would
decrease.
Compared to FLIM, sRET analysis has several important
advantages for imaging protein-protein interactions in living
cells. As mentioned above, sRET analysis required less time
than ﬂuorescent lifetime imaging. Thus, to minimize photo-
toxicity or bleaching or to achieve higher temporal re-
solutions in time-lapse studies, sRET analysis was preferable
on our microscope. FLIM analysis typically monitors RET
efﬁciencies by measuring changes in the ﬂuorescence
lifetime of the donor alone, whereas spectral imaging and
sRET analysis monitors intensity changes in both the donor
and the acceptor. As a result, RET images generated by
sRET analysis are less susceptible to artifacts caused by
nonspeciﬁc quenchers. Multiexponential analysis of lifetime
data can potentially discriminate between components trans-
ferring energy by RET from those that do not (7). Likewise,
the ratio of fast and slow decay constant amplitudes from
such an analysis can yield the ratio of components under-
going RET from those that are not (7). Multiexponential
curve ﬁtting is integral to this form of analysis and requires
many more detected photons than were acquired in our
FLIM analysis in Fig. 5. Thus, the relative photon efﬁciency
would be much worse if such an analysis was conducted.
Furthermore, multiexponential lifetime analysis is problem-
atic in samples containing a distribution of donor-acceptor
distances. This, evidently, was the case for our CV, CVC,
and VCV constructs (as indicated by the curved decay traces
in Fig. 1 b). In contrast, sRET analysis yielded the correct
donor and acceptor concentrations for these constructs as
well as the correct RET efﬁciencies.
APPENDIX: DERIVATION OF EQ. 2
For quantitative spectral analysis, it is assumed that ﬂuorescence excitation
is conducted under nonsaturating conditions; only a small fraction of the
ﬂuorophores present are excited at any instant in time. Furthermore,
emission from individual ﬂuorophores must not be altered during the course
of an experiment (e.g., no quenching, bleaching, or excimer formation).
Under these conditions, an equation describing the shape and magnitude of
the complex emission spectrum, Fcomplex, of a sample composed of two
ﬂuorophores in the absence of RET requires two summed terms. Each term
consists of a scalar to describe the magnitude of the emission from each
ﬂuorophore and a unit emission spectrum that describes the wavelength-
dependent distribution of the emission for a ﬁxed amount of that ﬂuorophore
at a set excitation wavelength and power and for a deﬁned instrumental
setup. The complete equation can be described as the abundance-weighted
sum of the emission spectra of the two independent spectral components:
Fcomplex ¼ d3Fd1 a3Fa (A1)
The ﬁrst term, d3 Fd, accounts for the emission of the donor and scales with
the abundance of the donor; d is proportional to the abundance of the donor,
and Fd is the unit emission spectrum of the donor. The second term, a3 Fa,
accounts for the emission of the acceptor as a result of its direct excitation. It
scales with the abundance of the acceptor; a is proportional to the abundance
of the acceptor, and Fa is the corresponding unit emission spectrum of the
acceptor.
A description of the complex emission spectrum of a sample containing
two ﬂuorophores when RET is occurring requires three terms to deﬁne the
three types of emission events that can occur. The ﬁrst term must account for
emission by the donor. The second accounts for emission by the acceptor as
a result of direct excitation. Finally, the third term must account for emission
by the acceptor resulting from RET. Each of these summed terms will
consist of a scalar and an appropriate unit emission spectrum. Because the
ﬁrst term involves emission by donors and the last two terms describe
emission by acceptors, the ﬁrst term must use the unit emission spectrum of
the donor, whereas the last two terms must use the unit emission spectrum of
the acceptor. An expression for each of these three scalars terms will be
derived.
The ﬁrst term accounts for emission by the donor after a fraction of its
absorbed energy has been transferred to acceptors. Let E equal the RET
efﬁciency, deﬁned as the fraction of donor excitation events that result in
energy transfer to the acceptor. Then, 1  E equals the fraction of donor
excitation events that are not transferred to acceptors, and the scalar of the
new ﬁrst term is
d3 ð1 EÞ
and the complete term (scalar multiplied by the unit emission spectrum) is
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d3 ð1 EÞ3Fd (A2)
As expected, in the absence of RET, E ¼ 0, and this term reduces to its
original form described in the ﬁrst half of Eq. A1.
The scalar for the second term of Eq. A1 described the magnitude of the
directly excited emission of acceptors. It is not altered by RET and at any
speciﬁc excitation wavelength and power remains simply proportional to the
abundance of acceptor molecules in the sample, a. The second term remains
a3Fa (A3)
RET requires an interaction between a donor molecule in its excited state
with a neighboring acceptor molecule in its ground state. After RET the
donor is in its ground state, and the acceptor is in its excited state. RET is
nonradiative; it does not involve the emission of a photon by the donor or the
absorption of a photon by the acceptor. The third term of a comprehensive
equation describing the shape and magnitude of the complex emission
spectrum of a sample containing two ﬂuorophores must account for energy
transferred from donors to acceptors and ultimately emitted by the acceptor.
Because this term describes emission from acceptors, it too, like the previous
term (Eq. A3), will have the form of a scalar multiplied by the unit emission
spectrum of the acceptor. The amount of energy transferred by RET will be
a function of the donor concentration (d) and the RET efﬁciency (E). The
scalar for this term must incorporate these variables without violating
conservation of energy. To this end, differences in the quantum yields of
donors (Fd) and acceptors (Fa) must be considered, as well as differences in
the shapes and magnitudes of the unit emission spectra of donors (Fd) and
acceptors (Fa). To derive this scalar, we will begin by determining how
many quanta of energy a donor absorbs in the absence of RET. If d 3 Fd
describes the shape and magnitude of a donor’s emission in the absence of
RET, then d 3
R
Fddl is proportional to the number of photons emitted as
ﬂuorescence. Division by the donor’s quantum yield, Fd, produces d 3R
Fddl/Fd, proportional to the number of photons absorbed. When RET
occurs, the fraction of quanta absorbed, whose energy is transferred to
acceptors is
E3 ½d3
Z
Fddl=Fd
The fraction of this energy emitted by the acceptor as ﬂuorescence, however,
will be attenuated by the acceptor’s nonradiative pathways. Thus, the energy
transferred from the donor to the acceptor and emitted as ﬂuorescence will be
proportional to
Fa3 ½E3 d3
Z
Fddl=Fd (A4)
To convert this expression into a scalar (to be multiplied by the unit emission
spectrum of the acceptor) requires a conversion factor equating photon-
energy and scalar magnitude. This conversion factor will be unique for
speciﬁc acceptors imaged under deﬁned conditions. Because photon energy
is proportional to a scalar 3
R
Fdl, conversion requires division by
R
Fdl.
Thus, the scalar for the third term of our equation is Eq. A4 divided byR
Fadl:
½Fa3E3 d3
Z
Fddl=Fd=
Z
Fadl (A5)
Rearrangement of Eq. A5 yields
d3E3 ðFa=FdÞ3 kðlÞ
where we deﬁne the k transfer factor, k(l), as
R
Fddl/
R
Fadl. This transfer
factor is a function of the excitation wavelength (as well as of the properties
of the imaging system) and must be evaluated for each speciﬁc donor-
acceptor pair.
The complete third term, scalar multiplied by the unit emission spectrum,
is
½d3E3 ðFa=FdÞ3 kðlÞ3Fa (A6)
As expected, in the absence of RET, E ¼ 0, and the entire third term is
eliminated.
The complex emission spectrum of a sample composed of donors and
acceptors, even if they transfer energy by RET, is deﬁned by the sum of the
three emission terms. The ﬁrst term accounts for emission by the donor (Eq.
A2), the second accounts for acceptor emission stimulated by direct
excitation (Eq. A3), and the third term accounts for acceptor emission
resulting from RET (Eq. A6). Thus, the complex spectrum is described by
Fcomplex ¼ d3 ð1 EÞ3Fd1 a3Fa1 d3E3 ðFa=FdÞ
3 kðlÞ3Fa: (A7)
Equation A7 is identical to Eq. 2 in the main text and reduces to Eq. A1 when
RET does not occur.
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